| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 19.06. | Neurizon, Elanco Ink Long-Term Supply Agreement for Human Health Monepantel | ||
| 19.06. | SK Pharmteco Partners with OTXL to Tackle Rare Diseases | ||
| 19.06. | PHCNA Launches CO2 Incubator Line for Cell-Culture Labs | ||
| 19.06. | ProChem Acquires Evonik Pharma Production Assets | ||
| 18.06. | Gandeeva, Zymeworks Using Cryo-EM to Enhance Antibody Drug Discovery | ||
| 18.06. | Nortiva Bio Launches, Developing Long-Acting Oral Medicines Via Proprietary Platform | ||
| 18.06. | Merck's Capvaxive Approved by FDA for Additional Indication in Pediatric Pneumococcal Disease | ||
| 18.06. | Alcami Announces Strategic & Operational Investments at Tennessee Facility | ||
| 18.06. | Minaris Expands GMP Cell Banking Capabilities in Philadelphia | ||
| 18.06. | WuXi Biologics Suzhou Center Passes EMA GMP Inspection | ||
| 18.06. | Pfizer Announces Search for New Chief Financial Officer | ||
| 18.06. | Biogen Agrees to Acquire RayThera for Up to $1B | ||
| 17.06. | Single Use Support Unveils RoSS.BLST Next-Gen Blast Freezer | ||
| 17.06. | Vedana Therapeutics Launches as Developer of Next-Gen Migraine Therapies | ||
| 17.06. | Jazz Pharma, AbCellera Collaborate on Next-Gen T-Cell Engaging Antibody Discovery | ||
| 17.06. | Bristol Myers Squibb Appoints GM of Saudi Arabia and Gulf Countries | ||
| 17.06. | Movianto Expands Capacity at Aalast, Belgium Facility | ||
| 16.06. | Syremis Therapeutics Adds Aaron Koenig as Chief Medical Officer | ||
| 16.06. | Intravacc, SynphaBase Unite to Support Conjugate Vaccine Development and Supply | ||
| 16.06. | Forge, Skylark Ink Strategic AAV Development, cGMP Manufacturing Agreement | ||
| 16.06. | GeneDx Names Mark Gardner as President | ||
| 16.06. | TriLink Opens GMP Enzyme Manufacturing Facility in Jupiter, FL | ||
| 16.06. | Neuland Laboratories to Invest $20 Million in Hyderabad Process-Development Facility | ||
| 16.06. | Codis Adds Business Development Leaders | ||
| 16.06. | Mabion Enters Rare Disease Collaboration with Oddifact |